A commonly used Chinese herbal formula, Shu-Jing-Hwo-Shiee-Tang, potentiates anticoagulant activity of warfarin in a rabbit model

Molecules

Volumn 18, Issue 10, 2013, Pages 11712-11723

  Yang, Sien Hung ^a,b   Yu, Chia Li ^c,d   Chen, Hsing Yu ^a,b   Lin, Yi Hsuan ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chinese herbal medicine; Herb drug interaction; Shu Jing Hwo Shiee Tang; Traditional Chinese Medicines; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; HERBACEOUS AGENT; SHU JING HWO SHIEE TANG; SHU-JING-HWO-SHIEE-TANG; WARFARIN;

ANIMAL; ARTICLE; BLOOD CLOTTING; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; MALE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RABBIT; THROMBIN TIME; DRUG EFFECTS;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; MALE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RABBITS; THROMBIN TIME; WARFARIN;

EID: 84886613372     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules181011712     Document Type: Article

References (20)

1. Almadi, M.A.; Barkun, A.; Brophy, J. Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding: An 86-year-old woman with peptic ulcer disease. JAMA 2011, 306, 2367-2374.
2. Tsai, H.H.; Lin, H.W.; Lu, Y.H.; Chen, Y.L.; Mahady, G.B. A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines. PLoS One 2013, 8, e64255.
3. Nutescu, E.A.; Shapiro, N.L.; Ibrahim, S.; West, P. Warfarin and its interactions with foods, herbs and other dietary supplements. Expert Opin. Drug Saf. 2006, 5, 433-451.
4. Samuels, N., Herbal remedies and anticoagulant therapy. Thromb. Haemost. 2005, 93, 3-7.
5. Lo, A.C.; Chan, K.; Yeung, J.H.; Woo, K.S. Danggui (Angelica sinensis) affects the pharmacodynamics but not the pharmacokinetics of warfarin in rabbits. Eur. J. Drug Metab. Pharmacokinet. 1995, 20, 55-60.
6. Chen, Y.; Fan, G.; Chen, B.; Xie, Y.; Wu, H.; Wu, Y.; Yan, C.; Wang, J. Separation and quantitative analysis of coumarin compounds from Angelica dahurica (Fisch. ex Hoffm) Benth. et Hook. f by pressurized capillary electrochromatography. J. Pharm. Biomed. Anal. 2006, 41, 105-116.
7. Mu, Y.; Zhang, J.; Zhang, S.; Zhou, H.H.; Toma, D.; Ren, S.; Huang, L.; Yaramus, M.; Baum, A.; Venkataramanan, R.; Xie, W. Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. J. Pharmacol. Exp. Ther. 2006, 316, 1369-1377.
8. Shalansky, S.; Lynd, L.; Richardson, K.; Ingaszewski, A.; Kerr, C. Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: A longitudinal analysis. Pharmacotherapy 2007, 27, 1237-1247.
9. Heck, A.M.; DeWitt, B.A.; Lukes, A.L. Potential interactions between alternative therapies and warfarin. Am. J. Health Syst. Pharm. 2000, 57, 1221-1227.
10. Page, R.L., 2nd; Lawrence, J.D. Potentiation of warfarin by dong quai. Pharmacotherapy 1999, 19, 870-876.
11. Lesho, E.P.; Saullo, L.; Udvari-Nagy, S. A 76-year-old woman with erratic anticoagulation. Cleve. Clin. J. Med. 2004, 71, 651-656.
12. Liapina, L.A.; Ammosova Ia, M.; Novikov, V.S.; Osipova, N.N.; Smolina, T.; Pastorova, V.E.; Uspenskaia, M.S.; Liapin, G. The nature of an anticoagulant isolated from peonies in the central zone of Russia. Izv. Akad. Nauk. Ser. Biol. 1997, 1997, 235-237.
13. Wu, L.C.; Lin, X.; Sun, H. Tanshinone IIA protects rabbits against LPS-induced disseminated intravascular coagulation (DIC). Acta Pharmacol. Sin. 2012, 33, 1254-1259.
14. Chen, X.W.; Sneed, K.B.; Pan, S.Y.; Cao, C.; Kanwar, J.R.; Chew, H.; Zhou, S.F. Herb-drug interactions and mechanistic and clinical considerations. Curr. Drug Metab. 2012, 13, 640-651.
15. Shi, S.; Klotz, U. Drug interactions with herbal medicines. Clin. Pharmacokinet. 2012, 51, 77-104.
16. Verhoef, T.I.; Redekop, W.K.; Daly, A.K.; van Schie, R.M.; de Boer, A.; Maitland-van der Zee, A.H. Pharmacogenetic-guided dosing of coumarin anticoagulants: Algorithms for warfarin, acenocoumarol and phenprocoumon. Br. J. Clin. Pharmacol. 2013, doi:10.1111/bcp.12220.
17. Zhan, C.; Yang, J. Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Pharmacol. Res. 2006, 53, 303-309.
18. Tawata, M.; Aida, K.; Noguchi, T.; Ozaki, Y.; Kume, S.; Sasaki, H.; Chin, M.; Onaya, T. Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice. Eur. J. Pharmacol. 1992, 212, 87-92.
19. Jin, Y.R.; Han, X.H.; Zhang, Y.H.; Lee, J.J.; Lim, Y.; Chung, J.H.; Yun, Y.P. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity. Atherosclerosis 2007, 194, 144-152.
20. U.S. Department of Health and Human Services; Food and Drug Administration; Center for Drug Evaluation and Research CDER. Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. Available online: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm078932.pdf (accessed on 16 September 2013).